Clinical Trial Update: Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders [Phase 4]

View source ↗

Summary

Phase 4 trial of Vivitrol (naltrexone) evaluated its effect on reducing driving-while-impaired behavior among repeat offenders; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Pacific Institute for Research and Evaluation | Conditions: Alcohol Consumption | Phase 4 | Status: COMPLETED | Results posted: 2012-08-27